The changing characteristics of patients with chronic hepatitis C prescribed direct acting antiviral medicines in general practice since listing of the medicines on the Australian Pharmaceutical Benefits Scheme
Abstract Background and Aim The primary objective of this study was to determine whether the characteristics of patients prescribed direct acting antiviral (DAA) medicines have changed since initial listing of the medicines on the Australian Pharmaceutical Benefits Scheme (PBS). Methods A cross‐sect...
Main Authors: | Doreen Busingye, Kendal Chidwick, Vanessa Simpson, Jonathan Dartnell, Gregory JDore, Anne Balcomb, Suzanne Blogg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12593 |
Similar Items
-
Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study
by: Andrea L Schaffer, et al.
Published: (2021-01-01) -
Generic medicine and prescribing: A quick assessment
by: Mainul Haque
Published: (2017-01-01) -
Australian podiatrists scheduled medicine prescribing practices and barriers and facilitators to endorsement: a cross‐sectional survey
by: Kristin Graham, et al.
Published: (2022-01-01) -
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
by: Elizabeth A. Cairns, et al.
Published: (2023-06-01) -
Medicinal Fungi with Antiviral Effect
by: Yu Zhang, et al.
Published: (2022-07-01)